Thomas F. Kissinger Elected to The Marcus Corporation Board of Directors
MILWAUKEE--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:52
RAZ Mobility Launches Accessible and Innovative Smartphone for People Who Are Blind or Visually Impaired
CABIN JOHN, Md.--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:52
Stocks are having their best run since 2021. Can they beat the August doldrums?
US markets just wrapped up a winning July, with the S&P 500 and Nasdaq both notching their fifth positive month in a row.
2023-08-01 19:46
Norwegian Cruise projects third-quarter profit below estimates as costs bite
(Reuters) -Norwegian Cruise Line Holdings forecast third-quarter profit below estimates on Tuesday, as higher fuel costs reverse its gains from
2023-08-01 19:45
United Natural Foods and Crisp Unveil New Platform Giving Consumer Packaged Goods Companies Enhanced Access to Retail Insights
PROVIDENCE, R.I.--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:28
FPT Software Earns Sitecore’s Rising Star Award 2023
HANOI, Vietnam--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:26
Defense firm Leidos raises annual revenue outlook on weapons demand
Leidos Holdings Inc on Tuesday raised its full-year revenue forecast as the defense contractor benefited from resilient weapons
2023-08-01 19:26
Western Exploration Provides Update on Geophysics and Drilling Activities at Doby George and Gravel Creek, Aura Project, NV
VANCOUVER--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:26
Pfizer Misses Quarterly Sales Estimates, Lowering Outlook
Pfizer Inc. missed revenue estimates for the second quarter as sales of its Covid pill fell drastically short
2023-08-01 19:25
Azul Releases "OpenJDK Migration for Dummies," a Definitive Guidebook for Java DevOps and Migration Teams
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aug 1, 2023--
2023-08-01 19:15
Uniper Expects Plan by Year-End for German State Exit
Uniper SE expects the German government to lay out an exit strategy from the company by the end
2023-08-01 18:58
Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
2023-08-01 18:56